We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
1d
Zacks Investment Research on MSNAbbott Laboratories Gains 12.7% in a Year: What's Driving the Stock?Abbott Laboratories ABT has witnessed strong momentum in the past year. Shares of the company have risen 12.7% compared with the 9% growth of the industry during the same time frame. The S&P 500 ...
Today, Benzinga 's options scanner spotted 10 uncommon options trades for Abbott Laboratories. This isn't normal. The overall ...
The decision to allow a new trial could have implications for both the companies and families with babies born prematurely.
Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their ...
Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.
Missouri 22nd Judicial Circuit Court Judge Michael Noble granted the plaintiff's motion for a new trial on Thursday, citing ...
As for earnings, ABT’s fourth-quarter fiscal 2024 earnings report showed sales growth of 9.5% for the year (excluding COVID ...
Abbott Laboratories (NYSE:ABT – Free Report) had its price objective boosted by The Goldman Sachs Group from $138.00 to ...
Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that ...
Abbott, a manufacturer of diagnostics and medical devices, sent a film crew to highlight Auburn Community Hospital's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results